加齢黄斑変性(AMD):世界の臨床試験レビュー(2014年上半期)...市場調査レポートについてご紹介

【英文タイトル】Age Related Macular Degeneration Global Clinical Trials Review, H1, 2014

▼当市場調査レポートの詳細内容確認、お問い合わせ及びご購入申込は下記ページでお願いします。▼マーケットレポート

【レポートの概要(一部)】

Table of Contents
Table of Contents 2
List of Tables 4
List of Figures 5
Introduction 6
Age Related Macular Degeneration 6
Report Guidance 6
Clinical Trials by Region 7
Clinical Trials and Average Enrollment by Country 8
Top Five Countries Contributing to Clinical Trials in Asia-Pacific 10
Top Five Countries Contributing to Clinical Trials in Europe 11
Top Countries Contributing to Clinical Trials in North America 12
Top Countries Contributing to Clinical Trials in Middle East and Africa 13
Top Five Countries Contributing to Clinical Trials in Central and South America 14
Clinical Trials by G7 Countries: Proportion of Age Related Macular Degeneration to Ophthalmology Clinical Trials 15
Clinical Trials by Phase in G7 Countries 16
Clinical Trials in G7 Countries by Trial Status 17
Clinical Trials by E7 Countries: Proportion of Age Related Macular Degeneration to Ophthalmology Clinical Trials 18
Clinical Trials by Phase in E7 Countries 19
Clinical Trials in E7 Countries by Trial Status 20
Clinical Trials by Phase 21
In Progress Trials by Phase 22
Clinical Trials by Trial Status 23
Clinical Trials by End Point Status 24
Unaccomplished Trials of Age Related Macular Degeneration 25
Subjects Recruited Over a Period of Time 31
Clinical Trials by Sponsor Type 32
Prominent Sponsors 33
Top Companies Participating in Age Related Macular Degeneration Therapeutics Clinical Trials 34
Prominent Drugs 36
Latest Clinical Trials News on Age Related Macular Degeneration 37
Feb 12, 2014: StemCells Announces Completion of the First of Two Cohorts in its Dry Age-Related Macular Degeneration Trial 37
Dec 09, 2013: QLT Announces First Patient Dosed in Phase IIa Proof-of-Concept Trial for QLT091001 in Impaired Dark Adaptation 37
Sep 12, 2013: Stemcells, Inc. Announces First High-Dose Patient Transplanted in Phase I/II Clinical Trial in Dry Age-Related Macular Degeneration 37
Aug 29, 2013: Ophthotech Enrolls First Patient in Phase 3 Clinical Trial of Fovista Anti-PDGF Therapy in Combination with Anti-VEGF Therapy for Wet AMD 38
Aug 27, 2013: Acucela Reaches 50% Enrollment in the Emixustat Hydrochloride Phase 2b/3 Clinical Trial 38
Clinical Trial Profiles 40
Clinical Trial Overview of Top Companies 40
Novartis AG 40
Clinical Trial Overview of Novartis AG 40
F. Hoffmann-La Roche Ltd. 47
Clinical Trial Overview of F. Hoffmann-La Roche Ltd. 47
Pfizer Inc. 51
Clinical Trial Overview of Pfizer Inc. 51
Bayer AG 54
Clinical Trial Overview of Bayer AG 54
Regeneron Pharmaceuticals, Inc. 56
Clinical Trial Overview of Regeneron Pharmaceuticals, Inc. 56
QLT Inc. 58
Clinical Trial Overview of QLT Inc. 58
Ophthotech Corp. 59
Clinical Trial Overview of Ophthotech Corp. 59
GlaxoSmithKline plc 60
Clinical Trial Overview of GlaxoSmithKline plc 60
Allergan, Inc. 61
Clinical Trial Overview of Allergan, Inc. 61
Valeant Pharmaceuticals International, Inc. 62
Clinical Trial Overview of Valeant Pharmaceuticals International, Inc. 62
Clinical Trial Overview of Top Institutes / Government 63
National Eye Institute 63
Clinical Trial Overview of National Eye Institute 63
Medical University of Vienna 65
Clinical Trial Overview of Medical University of Vienna 65
The Ludwig Boltzmann Institute of Retinology and Biomicroscopic Laser Surgery 67
Clinical Trial Overview of The Ludwig Boltzmann Institute of Retinology and Biomicroscopic Laser Surgery 67
Manhattan Eye Ear & Throat Hospital 68
Clinical Trial Overview of Manhattan Eye Ear & Throat Hospital 68
Johns Hopkins University 69
Clinical Trial Overview of Johns Hopkins University 69
U.S. Department of Veterans Affairs 70
Clinical Trial Overview of U.S. Department of Veterans Affairs 70
Lawson Health Research Institute 71
Clinical Trial Overview of Lawson Health Research Institute 71
Vitreous-Retina-Macula Consultants of New York 72
Clinical Trial Overview of Vitreous-Retina-Macula Consultants of New York 72
University of California, Davis 73
Clinical Trial Overview of University of California, Davis 73
Kyoto University 74
Clinical Trial Overview of Kyoto University 74
Five Key Clinical Profiles 75
Appendix 203
Abbreviations 203
Definitions 203
Research Methodology 204
Secondary Research 204
About GlobalData 205
Contact Us 205
Disclaimer 205
Source 205


【レポート販売概要】

■ タイトル:加齢黄斑変性(AMD):世界の臨床試験レビュー(2014年上半期)
■ 英文:Age Related Macular Degeneration Global Clinical Trials Review, H1, 2014
■ 発行日:2014年2月28日
■ 調査会社:GlobalData
■ 商品コード:GDHC2010CTIDB
■ 調査対象地域:グローバル
※当サイトは世界の市場調査レポート紹介サイトです。市場規模、市場動向、市場予測など、多様な分析データを含むグローバル調査レポートをご案内致します。日本国内を含むアジア太平洋、中国、ヨーロッパ、アメリカ、北米、中南米、中東、アフリカ地域などにおける、製品、サービス、技術、企業(メーカー、ベンダー)、市場シェア、市場環境など多様な項目に対応致します。当サイトでご紹介するレポートは「市場調査レポート販売サイトのMarketReport.jp」でお問い合わせ及びご購入可能です。